SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Haritz Jiménez-Urbieta, Belén Gago, Patricia de la Riva, Manuel Delgado-Alvarado, Concepció Marin, María C. Rodriguez-Oroz, Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches, Neuroscience & Biobehavioral Reviews, 2015, 56, 294

    CrossRef

  2. 2
    Nicolas Morin, Marc Morissette, Laurent Grégoire, Thérèse Di Paolo, Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015, 56, 27

    CrossRef

  3. 3
    Rui Zhao, Weijian Lu, Xing Fang, Lin Guo, Zhi Yang, Na Ye, Jiahao Zhao, Zhili Liu, Jia Jia, Longtai Zheng, Bin Zhao, Ao Zhang, Xuechu Zhen, (6aR)-11-Amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease, Pharmacology Biochemistry and Behavior, 2014, 124, 204

    CrossRef

  4. 4
    Andrew J. Flores, Mitchell J. Bartlett, Lisa Y. So, Nicholas D. Laude, Kate L. Parent, Michael L. Heien, Scott J. Sherman, Torsten Falk, Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model, Neuroscience Letters, 2014, 564, 48

    CrossRef

  5. 5
    Zsófia Majláth, László Vécsei, NMDA antagonists as Parkinson’s disease therapy: disseminating the evidence, Neurodegenerative Disease Management, 2014, 4, 1, 23

    CrossRef

  6. 6
    Albert Y. Hung, Michael A. Schwarzschild, Treatment of Parkinson’s Disease: What’s in the Non-dopaminergic Pipeline?, Neurotherapeutics, 2014, 11, 1, 34

    CrossRef

  7. 7
    Paul Carrillo-Mora, Daniela Silva-Adaya, Karla Villaseñor-Aguayo, Glutamate in Parkinson's disease: Role of antiglutamatergic drugs, Basal Ganglia, 2013, 3, 3, 147

    CrossRef